(Q41582325)

4 October 2017

1 reference

title

The non-random distribution of point mutations in leukaemia and myelodysplasia--a possible pointer to their aetiology (English)

1 reference

4 October 2017

1 reference

Parry TE

1

1 reference

4 October 2017

publication date

1 June 1997

1 reference

4 October 2017

1 reference

4 October 2017

volume

21

1 reference

4 October 2017

issue

6

1 reference

4 October 2017

page(s)

559-574

1 reference

Serum Uracil Levels in Acute Childhood Leukaemia

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

Adenosine deaminase (ADA) in leukemia: clinical value of plasma ADA activity and characterization of leukemic cell ADA

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

Two possible metabolic blocks in DNA synthesis that could be mutagenic

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

Serum 'uracil plus uridine' levels in normal subjects and their possible significance

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

Analysis of p53 gene mutations in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

Mutation analysis of the N-ras proto-oncogene in active and remission phase of human acute leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

RAS gene mutations in childhood acute myeloid leukemia: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

Analysis of ras gene mutations in childhood myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

Absence of hereditary p53 mutations in 10 familial leukemia pedigrees

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

Mutations of the P53 gene in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

P53 gene mutations in acute myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

Mutations of the p53 tumour suppressor gene in haematologic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

ras Oncogene Activation and Occupational Exposures in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

Occurrence of point mutations in p53 gene is not increased in patients with acute myeloid leukaemia carrying an activating N-ras mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

Clonal analysis of multiple point mutations in the N-ras gene in patients with acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

Frequency of RAS and p53 mutations in acute promyelocytic leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

High incidence of conservative RAS mutations in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

High frequency of RAS oncogene mutation in chronic myeloid leukemia patients with myeloblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

p53 mutation in the myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

Changing p53 mutations with the evolution of chronic myeloid leukaemia from the chronic phase to blast crisis.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

Acute leukemic transformation of myelodysplastic syndrome--immunophenotypic, genotypic, and cytogenetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2983221-3

7 January 2021

10.1016/S0145-2126(97)83221-3

Identifiers

DOI

1 reference

4 October 2017

1 reference